These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 26836271)
1. Attenuation of a select agent-excluded Burkholderia pseudomallei capsule mutant in hamsters. Gutierrez MG; Warawa JM Acta Trop; 2016 May; 157():68-72. PubMed ID: 26836271 [TBL] [Abstract][Full Text] [Related]
2. Burkholderia pseudomallei JW270 Is Lethal in the Madagascar Hissing Cockroach Infection Model and Can Be Utilized at Biosafety Level 2 to Identify Putative Virulence Factors. Chua J; Nguyenkhoa E; Mou S; Tobery SA; Friedlander AM; DeShazer D Infect Immun; 2022 Aug; 90(8):e0015922. PubMed ID: 35862734 [TBL] [Abstract][Full Text] [Related]
3. A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists. Propst KL; Mima T; Choi KH; Dow SW; Schweizer HP Infect Immun; 2010 Jul; 78(7):3136-43. PubMed ID: 20404077 [TBL] [Abstract][Full Text] [Related]
4. Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis. Warawa JM; Long D; Rosenke R; Gardner D; Gherardini FC Infect Immun; 2009 Dec; 77(12):5252-61. PubMed ID: 19752033 [TBL] [Abstract][Full Text] [Related]
6. Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Moore RA; Reckseidler-Zenteno S; Kim H; Nierman W; Yu Y; Tuanyok A; Warawa J; DeShazer D; Woods DE Infect Immun; 2004 Jul; 72(7):4172-87. PubMed ID: 15213162 [TBL] [Abstract][Full Text] [Related]
7. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model. Warawa J; Woods DE FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426 [TBL] [Abstract][Full Text] [Related]
8. LVS Δ Tullius MV; Bowen RA; Back PS; Masleša-Galić S; Nava S; Horwitz MA mBio; 2024 Apr; 15(4):e0018624. PubMed ID: 38511933 [TBL] [Abstract][Full Text] [Related]
9. The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice. Norris MH; Propst KL; Kang Y; Dow SW; Schweizer HP; Hoang TT Infect Immun; 2011 Oct; 79(10):4010-8. PubMed ID: 21807903 [TBL] [Abstract][Full Text] [Related]
10. Type 3 secretion system cluster 3 is a critical virulence determinant for lung-specific melioidosis. Gutierrez MG; Pfeffer TL; Warawa JM PLoS Negl Trop Dis; 2015 Jan; 9(1):e3441. PubMed ID: 25569630 [TBL] [Abstract][Full Text] [Related]
11. Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils. Woodman ME; Worth RG; Wooten RM PLoS One; 2012; 7(12):e52276. PubMed ID: 23251706 [TBL] [Abstract][Full Text] [Related]
13. Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. Atkins T; Prior R; Mack K; Russell P; Nelson M; Prior J; Ellis J; Oyston PCF; Dougan G; Titball RW J Med Microbiol; 2002 Jul; 51(7):539-553. PubMed ID: 12132769 [TBL] [Abstract][Full Text] [Related]
14. Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis. Rodrigues F; Sarkar-Tyson M; Harding SV; Sim SH; Chua HH; Lin CH; Han X; Karuturi RK; Sung K; Yu K; Chen W; Atkins TP; Titball RW; Tan P J Bacteriol; 2006 Dec; 188(23):8178-88. PubMed ID: 16997946 [TBL] [Abstract][Full Text] [Related]
15. Genome-wide expression analysis of Burkholderia pseudomallei infection in a hamster model of acute melioidosis. Tuanyok A; Tom M; Dunbar J; Woods DE Infect Immun; 2006 Oct; 74(10):5465-76. PubMed ID: 16988221 [TBL] [Abstract][Full Text] [Related]
16. An in situ high-throughput screen identifies inhibitors of intracellular Bulterys PL; Toesca IJ; Norris MH; Maloy JP; Fitz-Gibbon ST; France B; Toffig B; Morselli M; Somprasong N; Pellegrini M; Schweizer HP; Tuanyok A; Damoiseaux R; French CT; Miller JF Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18597-18606. PubMed ID: 31439817 [No Abstract] [Full Text] [Related]
17. Virulence of Burkholderia pseudomallei ATS2021 Unintentionally Imported to United States in Aromatherapy Spray. Cote CK; Mlynek KD; Klimko CP; Biryukov SS; Mou S; Hunter M; Rill NO; Dankmeyer JL; Miller JA; Talyansky Y; Davies ML; Meinig JM; Halasohoris SA; Gray AM; Spencer JL; Babyak AL; Hourihan MK; Curry BJ; Toothman RG; Ruiz SI; Zeng X; Ricks KM; Clements TL; Douglas CE; Ravulapalli S; Stefan CP; Shoemaker CJ; Elrod MG; Gee JE; Weiner ZP; Qiu J; Bozue JA; Twenhafel NA; DeShazer D Emerg Infect Dis; 2024 Oct; 30(10):2056-2069. PubMed ID: 39320153 [TBL] [Abstract][Full Text] [Related]
18. An avirulent Burkholderia pseudomallei ∆purM strain with atypical type B LPS: expansion of the toolkit for biosafe studies of melioidosis. Norris MH; Rahman Khan MS; Schweizer HP; Tuanyok A BMC Microbiol; 2017 Jun; 17(1):132. PubMed ID: 28592242 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region. Cuccui J; Milne TS; Harmer N; George AJ; Harding SV; Dean RE; Scott AE; Sarkar-Tyson M; Wren BW; Titball RW; Prior JL Infect Immun; 2012 Mar; 80(3):1209-21. PubMed ID: 22252864 [TBL] [Abstract][Full Text] [Related]